Selected References:
- Benyamini L, et al. 2005. The safety of amoxicillin/clavulanic acid and cefuroxime during lactation. Ther Drug Monit. 27(4):499–502.
- Boissiere-O’Neill T, et al. 2026. Exposure to Systemic Antimicrobials During Pregnancy and Risk of Miscarriage: A Population-Based Registry Study. BJOG 133(7):1394–1404.
- Chu YN, et al. 2019. Toxic epidermal necrolysis in an infant induced by drug intake through breast milk. Dermatologica Sinica. 37(2):86–89.
- Crider KS, et al. 2009. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Archives of Pediatrics & Adolescent Medicine, 163(11), 978–985.
- Czeizel AE, et al. 2001. Use of cephalosporins during pregnancy and in the presence of congenital anomalies: a population-based, case-control study. Am J Obstet Gynecol. 184(6):1289-1896.
- Ilett KF, et al. 2006. Transfer of probenecid and cephalexin into breast milk. Ann Pharmacother. 40(5):986–989.
- Ito S, et al. 1993. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 168(5):1393–1399.
- Kafetzi D, et al. 1981. Passage of cephalosporins and amoxicillin into the breast milk. Acta Paediatr Scand. 70(3):285-288.
- Rau A, et al. 2024. Management of Acne in Pregnancy, Am J Clin Dermatol. 25(3):465-471.
- Saad AF, et al. 2025. Prophylactic Oral Cephalexin and Metronidazole Compared With Placebo After Cesarean Delivery to Reduce Infection Complications in Women With Obesity: A Randomized Controlled Trial. Obstet Gynecol. 146(1):113-120.
- Teva Pharmaceuticals. 2020. Cephalexin product label. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=19307ff0-71de-477b-965d-ea243e5ede3a. [Accessed April 4 2026]
